nmvac4-a/c/y/w-135-dt
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2013 (NCT01897402)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Neisseria meningitidisImmunity, active
Neisseria meningitidis immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- nmvac4-a/c/y/w-135-dt
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01897402 | Phase 2 | Jul 1, 2013 | Chesapeake Research Group, LLC, IRC Clinics, Towson, JN-International Medical Corporation |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chesapeake Research Group, LLC | For profit | 1 | 0 | 1 | 2013 |
| IRC Clinics, Towson | Academic/Hospital | 1 | 0 | 1 | 2013 |
| JN-International Medical Corporation | For profit | 1 | 1 | 1 | 2013 |
3 organizations
Page 1 / 1